SEC Form 4 · accession 0001179110-15-013268
ACCELERON PHARMA INC · XLRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Matthew L Sherman
Officer — EVP & Chief Medical Officer
Period of report
Sep 9, 2015
Accepted (ET)
Sep 11, 2015 · 4:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001280600
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 9, 2015 | A | 46,000 | $0.00 | A | 98,004 | D | |
| Common Stock | holding | — | — | — | 10,100 | I | By GRAT |
Table II — derivative securities
No Table II lines on this filing.